2026 ICD-10-CM Diagnosis Code D37.8Neoplasm of uncertain behavior of other specified digestive organs

ICD-10-CM CodesC00–D49D37-D48D37

ICD-10-CM D37.8
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

D37.8 is a billable ICD-10-CM diagnosis code for neoplasm of uncertain behavior of other specified digestive organs. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 374 through 376. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasms of unspecified nature or uncertain behavior.

Code Identity

ICD-10-CM Code
D37.8
Billable Status
Yes — Valid for Submission
Code Describes
Neoplasm of uncertain behavior of other specified digestive organs
Short Description
Neoplasm of uncertain behavior of oth digestive organs
Parent Code
Neoplasm of uncertain behavior of oral cavity and digestive organs

Code Classification

ChapterC00–D49Neoplasms
SectionD37-D48Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes
CategoryD37Neoplasm of uncertain behavior of oral cavity and digestive organs
This CodeD37.8Neoplasm of uncertain behavior of other specified digestive organs

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Diffuse leiomyomatosis of esophagus
  • Glucagonoma syndrome
  • Hemangioblastoma of intestine
  • Hemangioblastoma of pancreas
  • Necrolytic migratory erythema
  • Neoplasm of body of pancreas
  • Neoplasm of head of pancreas
  • Neoplasm of tail of pancreas
  • Neoplasm of uncertain behavior of abdominal esophagus
  • Neoplasm of uncertain behavior of anal canal
  • Neoplasm of uncertain behavior of anal canal and sphincter
  • Neoplasm of uncertain behavior of anus
  • Neoplasm of uncertain behavior of body of pancreas
  • Neoplasm of uncertain behavior of cervical esophagus
  • Neoplasm of uncertain behavior of esophagus
  • Neoplasm of uncertain behavior of head of pancreas
  • Neoplasm of uncertain behavior of intestinal tract
  • Neoplasm of uncertain behavior of islets of Langerhans
  • Neoplasm of uncertain behavior of lower third of esophagus
  • Neoplasm of uncertain behavior of middle third of esophagus
  • Neoplasm of uncertain behavior of pancreas
  • Neoplasm of uncertain behavior of pancreatic duct
  • Neoplasm of uncertain behavior of soft tissues of perineum
  • Neoplasm of uncertain behavior of spleen
  • Neoplasm of uncertain behavior of tail of pancreas
  • Neoplasm of uncertain behavior of thoracic esophagus
  • Neoplasm of uncertain behavior of upper third of esophagus
  • Somatostatinoma

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Neoplasm of uncertain behavior of anal canal
  • Neoplasm of uncertain behavior of anal sphincter
  • Neoplasm of uncertain behavior of anus NOS
  • Neoplasm of uncertain behavior of esophagus
  • Neoplasm of uncertain behavior of intestine NOS
  • Neoplasm of uncertain behavior of pancreas

Type 1 Excludes

  • neoplasm of uncertain behavior of anal margin D48.5
  • neoplasm of uncertain behavior of anal skin D48.5
  • neoplasm of uncertain behavior of perianal skin D48.5

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Glucagonoma
      • pancreas
        • uncertain behavior
    • Glucagonoma
      • unspecified site
        • uncertain behavior
    • Insulinoma
      • pancreas
        • uncertain behavior
    • Insulinoma
      • unspecified site
        • uncertain behavior
    • Tumor
      • G cell
        • unspecified site

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO072
Neoplasms of unspecified nature or uncertain behavior
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Barrett Esophagus

    a condition with damage to the lining of the lower esophagus resulting from chronic acid reflux (esophagitis, reflux). through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the intestine or the salmon-pink mucosa of the stomach. barrett's columnar epithelium is a marker for severe reflux and precursor to adenocarcinoma of the esophagus.
  • Esophageal Motility Disorders

    disorders affecting the motor function of the upper esophageal sphincter; lower esophageal sphincter; the esophagus body, or a combination of these parts. the failure of the sphincters to maintain a tonic pressure may result in gastric reflux of food and acid into the esophagus (gastroesophageal reflux). other disorders include hypermotility (spastic disorders) and markedly increased amplitude in contraction (nutcracker esophagus).
  • Esophageal Mucosa

    circular innermost layer of the esophagus wall that mediates esophageal peristalsis which pushes ingested food bolus toward the stomach.
  • Esophageal Neoplasms

    tumors or cancer of the esophagus.
  • Esophagus

    the muscular membranous segment between the pharynx and the stomach in the upper gastrointestinal tract.
  • Carcinoma, Pancreatic Ductal

    carcinoma that arises from the pancreatic ducts. it accounts for the majority of cancers derived from the pancreas.
  • Cystic Fibrosis

    an autosomal recessive genetic disease of the exocrine glands. it is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator expressed in several organs including the lung, the pancreas, the biliary system, and the sweat glands. cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in airway obstruction; chronic respiratory infections; pancreatic insufficiency; maldigestion; salt depletion; and heat prostration.
  • Insulin Infusion Systems

    portable or implantable devices for infusion of insulin. includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
  • Islets of Langerhans

    irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the pancreas among the exocrine acini. each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. there are four major cell types. the most abundant beta cells (50-80%) secrete insulin. alpha cells (5-20%) secrete glucagon. pp cells (10-35%) secrete pancreatic polypeptide. delta cells (~5%) secrete somatostatin.
  • Nesidioblastosis

    an inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the pancreas and congenital hyperinsulinism. it is due to focal hyperplasia of pancreatic islet cells budding off from the ductal structures and forming new islets of langerhans. mutations in the islet cells involve the potassium channel gene kcnj11 or the atp-binding cassette transporter gene abcc8, both on chromosome 11.
  • Pancreas

    a nodular organ in the abdomen that contains a mixture of endocrine glands and exocrine glands. the small endocrine portion consists of the islets of langerhans secreting a number of hormones into the blood stream. the large exocrine portion (exocrine pancreas) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the duodenum.
  • Pancreas Divisum

    anatomic variants in pancreatic ducts characterized by failure of fusion of the ventral and dorsal endodermal buds. pancreas divisum results in inadequate or no communication between dorsal and ventral ducts. while most cases are asymptomatic, it may be associated with recurrent pancreatitis.
  • Pancreas Transplantation

    the transference of a pancreas from one human or animal to another.
  • Pancreas, Artificial

    devices for simulating the activity of the pancreas. they can be either electromechanical, consisting of a glucose sensor, computer, and insulin pump or bioartificial, consisting of isolated islets of langerhans in an artificial membrane.
  • Pancreas, Exocrine

    the major component (about 80%) of the pancreas composed of acinar functional units of tubular and spherical cells. the acinar cells synthesize and secrete several digestive enzymes such as trypsinogen; lipase; amylase; and ribonuclease. secretion from the exocrine pancreas drains into the pancreatic ductal system and empties into the duodenum.
  • Pancreatic Neoplasms

    tumors or cancer of the pancreas. depending on the types of islet cells present in the tumors, various hormones can be secreted: glucagon from pancreatic alpha cells; insulin from pancreatic beta cells; and somatostatin from the somatostatin-secreting cells. most are malignant except the insulin-producing tumors (insulinoma).
  • Pancrelipase

    a preparation of hog pancreatic enzymes standardized for lipase content.
  • Shwachman-Diamond Syndrome

    an inherited syndrome characterized by exocrine pancreatic insufficiency; hematologic abnormalities (e.g., bone marrow hypoplasia), and skeletal abnormalities (e.g., metaphyseal chondroplasia). germline mutations in the sbds gene are associated with shwachman-diamond syndrome.
  • Necrolytic Migratory Erythema

    recurrent cutaneous manifestation of glucagonoma characterized by necrolytic polycyclic migratory lesions with scaling borders. it is associated with elevated secretion of glucagon by the tumor. other conditions with elevated serum glucagon levels such as hepatic cirrhosis may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.
  • Somatostatinoma

    a somatostatin-secreting tumor derived from the pancreatic delta cells (somatostatin-secreting cells). it is also found in the intestine. somatostatinomas are associated with diabetes mellitus; cholelithiasis; steatorrhea; and hypochlorhydria. the majority of somatostatinomas have the potential for metastasis.

Table of NeoplasmsClinical

Anatomical sites in the Table of Neoplasms that reference this code family.

SiteMalig.
Primary
Malig.
Secondary
Ca
in situ
BenignUncertainUnspec.
anorectum, anorectal (junction)C21.8C78.5D01.3D12.9D37.8D49.0
anus, analC21.0C78.5D01.3D12.9D37.8D49.0
anus, anal canalC21.1C78.5D01.3D12.9D37.8D49.0
anus, anal cloacogenic zoneC21.2C78.5D01.3D12.9D37.8D49.0
anus, anal sphincterC21.1C78.5D01.3D12.9D37.8D49.0
canalC21.1C78.5D01.3D12.9D37.8D49.0
canal analC21.1C78.5D01.3D12.9D37.8D49.0
cloacogenic zoneC21.2C78.5D01.3D12.9D37.8D49.0
crypt of MorgagniC21.8C78.5D01.3D12.9D37.8D49.0
esophagusC15.9C78.89D00.1D13.0D37.8D49.0
esophagus abdominalC15.5C78.89D00.1D13.0D37.8D49.0
esophagus cervicalC15.3C78.89D00.1D13.0D37.8D49.0
esophagus distal (third)C15.5C78.89D00.1D13.0D37.8D49.0
esophagus lower (third)C15.5C78.89D00.1D13.0D37.8D49.0
esophagus middle (third)C15.4C78.89D00.1D13.0D37.8D49.0
esophagus proximal (third)C15.3C78.89D00.1D13.0D37.8D49.0
esophagus thoracicC15.4C78.89D00.1D13.0D37.8D49.0
esophagus upper (third)C15.3C78.89D00.1D13.0D37.8D49.0
hemorrhoidal zoneC21.1C78.5D01.3D12.9D37.8D49.0
insular tissue (pancreas)C25.4C78.89D01.7D13.7D37.8D49.0
intestine, intestinalC26.0C78.80D01.40D13.99D37.8D49.0
intestine, intestinal tract NECC26.0C78.89D01.40D13.99D37.8D49.0
islands or islets of LangerhansC25.4C78.89D01.7D13.7D37.8D49.0
junctionC21.8C78.5D01.3D12.9D37.8D49.0
junction anorectalC21.8C78.5D01.3D12.9D37.8D49.0
Langerhans, islands or isletsC25.4C78.89D01.7D13.7D37.8D49.0
pancreasC25.9C78.89D01.7D13.6D37.8D49.0
pancreas bodyC25.1C78.89D01.7D13.6D37.8D49.0
pancreas duct (of Santorini) (of Wirsung)C25.3C78.89D01.7D13.6D37.8D49.0
pancreas ectopic tissueC25.7C78.89D13.6D37.8D49.0
pancreas headC25.0C78.89D01.7D13.6D37.8D49.0
pancreas islet cellsC25.4C78.89D01.7D13.7D37.8D49.0
pancreas neckC25.7C78.89D01.7D13.6D37.8D49.0
pancreas tailC25.2C78.89D01.7D13.6D37.8D49.0
Santorini's ductC25.3C78.89D01.7D13.6D37.8D49.0
sphincterC21.1C78.5D01.3D12.9D37.8D49.0
sphincter analC21.1C78.5D01.3D12.9D37.8D49.0
spleen, splenic NECC26.1C78.89D01.7D13.99D37.8D49.0
Wirsung's ductC25.3C78.89D01.7D13.6D37.8D49.0

Patient EducationClinical

Digestive Diseases

When you eat, your body breaks food down to a form it can use to build and nourish cells and provide energy. This process is called digestion.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert D37.8 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
235.5 Unc behav neo GI NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About D37.8Overview

Is D37.8 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report neoplasm of uncertain behavior of other specified digestive organs on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does D37.8 group to?

When neoplasm of uncertain behavior of other specified digestive organs is the principal diagnosis on an inpatient stay, it groups to MS-DRG 374, 375, 376, with relative weights from 0.9243 to 2.1387 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of D37.8?

Under the General Equivalence Mappings, neoplasm of uncertain behavior of other specified digestive organs converts to ICD-9-CM 235.5 (unc behav neo GI NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.